BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28757171)

  • 1. Genetic determinants of cholangiopathies: Molecular and systems genetics.
    Reichert MC; Hall RA; Krawczyk M; Lammert F
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1484-1490. PubMed ID: 28757171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
    Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and extracellular vesicles in cholangiopathies.
    Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cholangiocyte responses to injury.
    Sato K; Meng F; Giang T; Glaser S; Alpini G
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1262-1269. PubMed ID: 28648950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.
    Strazzabosco M; Fiorotto R; Cadamuro M; Spirli C; Mariotti V; Kaffe E; Scirpo R; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1374-1379. PubMed ID: 28754453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced bile duct injury.
    Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
    J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
    Pinto C; Giordano DM; Maroni L; Marzioni M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
    Trauner M; Fickert P; Wagner M
    Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review.
    Strubbe B; Geerts A; Van Vlierberghe H; Colle I
    Acta Gastroenterol Belg; 2012 Dec; 75(4):405-10. PubMed ID: 23402083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repopulating the biliary tree from the peribiliary glands.
    de Jong IEM; van Leeuwen OB; Lisman T; Gouw ASH; Porte RJ
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1524-1531. PubMed ID: 28778591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment.
    Cariello M; Gadaleta RM; Moschetta A
    Curr Opin Gastroenterol; 2022 Mar; 38(2):136-143. PubMed ID: 35034082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the biliary tree maintains immune tolerance?
    Zhang H; Leung PSC; Gershwin ME; Ma X
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1367-1373. PubMed ID: 28844953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of cholestasis: An update on inflammatory cholangiopathies.
    Mariotti V; Cadamuro M; Spirli C; Fiorotto R; Strazzabosco M; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):954-964. PubMed ID: 30398152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathobiology of biliary epithelia.
    Cheung AC; Lorenzo Pisarello MJ; LaRusso NF
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1220-1231. PubMed ID: 28716705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic cholestasis: lessons from the molecular physiology of bile formation.
    Jansen PL; Müller M
    Can J Gastroenterol; 2000 Mar; 14(3):233-8. PubMed ID: 10758420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.